Who owns Vor Biopharma Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Vor Biopharma with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vor Biopharma stock

Who bought or sold Vor Biopharma Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Morgan Stanley 503.00 $814.860000 100% Jun 2025
 View chart

Who sold out of Vor Biopharma?

Fund or Company Name Date Sold Shares Held Valued At
RA Capital Management Jun 2025 40M $64M
5AM Venture Management Jun 2025 6.4M $10M
Susquehanna International Jun 2025 2.9M $4.6M
FMR Jun 2025 2.1M $3.4M
Vanguard Group Jun 2025 1.9M $3.1M
UBS Group Jun 2025 1.5M $2.5M
Jane Street Jun 2025 1.2M $1.9M
Johnson & Johnson Jun 2025 1.1M $1.1M
Citadel Advisors Jun 2025 757k $1.2M
Sarissa Capital Management Jun 2025 508k $823k
Hrt Financial Jun 2025 475k $768k
Renaissance Technologies Jun 2025 468k $758k
Geode Capital Management Jun 2025 436k $706k
Scientech Research Jun 2025 404k $654k
BlackRock Jun 2025 375k $607k
Virtu Financial Jun 2025 276k $447k
Two Sigma Investments Jun 2025 170k $275k
State Street Corporation Jun 2025 116k $188k
Millennium Management Jun 2025 110k $178k
Eisler Capital Management Jun 2025 101k $162k
Two Sigma Securities Jun 2025 94k $153k
Trustees of Columbia University in the City of New York Jun 2025 92k $149k
Goldman Sachs Group Mar 2025 85k $61k
Northern Trust Jun 2025 72k $117k
Bollard Jun 2025 56k $90k
LMR Partners Jun 2025 50k $81k
XTX Topco Jun 2025 41k $66k
Chicago Partners Investment Jun 2025 11k $23k
MAI Wealth Advisors Jun 2025 3.7k $5.9k
Tower Research Capital Jun 2025 2.3k $3.7k
Jpmorgan Chase & Co Mar 2025 1.9k $1.3k
Bnp Paribas Arbitrage, Snc Jun 2025 1.0k $1.6k
Nbc Securities Jun 2025 1.0k $1.0k